Divergent regional patterns of cerebral hypoperfusion and gray matter atrophy in mild cognitive impairment patients
暂无分享,去创建一个
Miranka Wirth | Agnes Flöel | Peter Brunecker | Theresa Köbe | Alexa Pichet Binette | A. Flöel | M. Wirth | T. Köbe | A. Witte | A Veronica Witte | P. Brunecker | A. Pichet Binette | Alexa Pichet Binette | A. V. Witte
[1] A. Fagan,et al. APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging , 2010, Annals of neurology.
[2] C. Jack,et al. MRI correlates of neurofibrillary tangle pathology at autopsy , 2008, Neurology.
[3] Anderson M. Winkler,et al. Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies , 2010, NeuroImage.
[4] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[5] David C. Alsop,et al. Hippocampal hyperperfusion in Alzheimer's disease , 2008, NeuroImage.
[6] Miranka Wirth,et al. Neuroprotective pathways: lifestyle activity, brain pathology, and cognition in cognitively normal older adults , 2014, Neurobiology of Aging.
[7] C. Iadecola. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia , 2010, Acta Neuropathologica.
[8] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[9] James T Becker,et al. Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. , 2009, Radiology.
[10] Norbert Schuff,et al. Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment. , 2014, Brain : a journal of neurology.
[11] B. Hyman,et al. Neuropathological alterations in Alzheimer disease. , 2011, Cold Spring Harbor perspectives in medicine.
[12] C. Jack,et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.
[13] Bernard Ng,et al. Regional brain hypometabolism is unrelated to regional amyloid plaque burden. , 2015, Brain : a journal of neurology.
[14] Jane Mummery,et al. Regional , 2019, M/C Journal.
[15] David L. Thomas,et al. Measuring Cerebral Blood Flow Using Magnetic Resonance Imaging Techniques , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[16] B. Rosen,et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis , 1996, Magnetic resonance in medicine.
[17] Manuel Desco,et al. Cerebral Blood Flow is an Earlier Indicator of Perfusion Abnormalities than Cerebral Blood Volume in Alzheimer's Disease , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[18] Vincent Doré,et al. In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[19] G. Alexander,et al. Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease , 2009, Proceedings of the National Academy of Sciences.
[20] W. Maier,et al. The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia , 2010, Psychiatry Research: Neuroimaging.
[21] N. Schuff,et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. , 2005, Radiology.
[22] R. Floris,et al. Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load. , 2001, AJNR. American journal of neuroradiology.
[23] C. Van Petten,et al. Relationship between hippocampal volume and memory ability in healthy individuals across the lifespan: review and meta-analysis. , 2004, Neuropsychologia.
[24] M. Essig,et al. Perfusion MRI: the five most frequently asked technical questions. , 2013, AJR. American journal of roentgenology.
[25] Helge Malmgren,et al. White Matter Lesion Assessment in Patients with Cognitive Impairment and Healthy Controls: Reliability Comparisons between Visual Rating, a Manual, and an Automatic Volumetrical MRI Method—The Gothenburg MCI Study , 2013, Journal of aging research.
[26] Salvatore Mazza,et al. Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights. , 2011, Journal of Alzheimer's disease : JAD.
[27] J B Poline,et al. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease. , 2007, Brain : a journal of neurology.
[28] Hiroshi Matsuda,et al. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT , 2005, NeuroImage.
[29] Anders M. Dale,et al. MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths , 2009, NeuroImage.
[30] B Fischl,et al. Correlations between MRI white matter lesion location and executive function and episodic memory , 2011, Neurology.
[31] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[32] S. Villeneuve,et al. Are AD-Typical Regions the Convergence Point of Multiple Pathologies? , 2015, Front. Aging Neurosci..
[33] Maja A. A. Binnewijzend,et al. Cerebral perfusion in the predementia stages of Alzheimer’s disease , 2015, European Radiology.
[34] C. Iadecola. Cerebrovascular Effects of Amyloid-ß Peptides: Mechanisms and Implications for Alzheimer's Dementia , 2003, Cellular and Molecular Neurobiology.
[35] R. Petersen,et al. Mild Cognitive Impairment: An Overview , 2008, CNS Spectrums.
[36] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .
[37] J. Morris,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.
[38] Xin Li,et al. High-Resolution Steady-State Cerebral Blood Volume Maps in Patients with Central Nervous System Neoplasms Using Ferumoxytol, a Superparamagnetic Iron Oxide Nanoparticle , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[39] Harald Hampel,et al. Reduced Hippocampal Volume in Healthy Young ApoE4 Carriers: An MRI Study , 2012, PloS one.
[40] Clifford R. Jack,et al. Interpreting scan data acquired from multiple scanners: A study with Alzheimer's disease , 2008, NeuroImage.
[41] Lippincott Williams Wilkins,et al. Higher glucose levels associated with lower memory and reduced hippocampal microstructure , 2014, Neurology.
[42] A. Beck,et al. Assessment of depression: the depression inventory. , 1974, Modern problems of pharmacopsychiatry.
[43] Michael Oliver Flüß,et al. Detection of changed regional cerebral blood flow in mild cognitive impairment and early Alzheimer's dementia by perfusion-weighted magnetic resonance imaging , 2008, NeuroImage.
[44] G. Chételat,et al. Region-Specific Hierarchy between Atrophy, Hypometabolism, and β-Amyloid (Aβ) Load in Alzheimer's Disease Dementia , 2012, The Journal of Neuroscience.
[45] J. Baron,et al. Relationships between Hippocampal Atrophy, White Matter Disruption, and Gray Matter Hypometabolism in Alzheimer's Disease , 2008, The Journal of Neuroscience.
[46] Koen Van Laere,et al. Validation of the cerebellum as a reference region for SPECT quantification in patients suffering from dementia of the Alzheimer type , 1999, Psychiatry Research: Neuroimaging.
[47] Sterling C. Johnson,et al. Effects of hypoperfusion in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.
[48] Christina E. Wierenga,et al. Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.
[49] Anders M. Dale,et al. Cortical Surface-Based Analysis I. Segmentation and Surface Reconstruction , 1999, NeuroImage.
[50] R. Mayeux,et al. Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease , 2013, Nature Neuroscience.
[51] Cees Jonker,et al. Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment , 1999, Journal of Neurology.
[52] Max Wintermark,et al. Perfusion MRI: the five most frequently asked clinical questions. , 2013, AJR. American journal of roentgenology.
[53] Miranka Wirth,et al. Alzheimer's Disease Neurodegenerative Biomarkers Are Associated with Decreased Cognitive Function but Not β-Amyloid in Cognitively Normal Older Individuals , 2013, The Journal of Neuroscience.
[54] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[55] Panagiotis AlexopoulosChristian. Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer's disease measured by pulsed arterial spin labeling MRI , 2011 .
[56] C. Iadecola,et al. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. , 2006, Journal of applied physiology.
[57] M. Pencina,et al. General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.
[58] S. Leh,et al. Arterial spin labeling imaging reveals widespread and Aβ-independent reductions in cerebral blood flow in elderly apolipoprotein epsilon-4 carriers , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[59] A. M. Saunders,et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.
[60] Anders M. Dale,et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.
[61] H. Matsuda. Cerebral blood flow and metabolic abnormalities in Alzheimer’s disease , 2001, Annals of nuclear medicine.
[62] Janet S. Reddin,et al. Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease , 2011, Neurology.
[63] Scott A. Small,et al. Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis , 2008, Neuron.